Paperpal Prime Logo

MedComm – Biomaterials and Applications : Impact Factor & More

eISSN: 2769-643X
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

MedComm – Biomaterials and Applications Journal Specifications

Indexed in the following public directories

  • DOAJ DOAJ
Overview
Publisher Wiley
Language English
Article Processing ChargesUSD 2600
Publication Time15
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorSichuan International Medical Exchange & Promotion Association (SCIMEA)
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 15
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in MedComm – Biomaterials and Applications ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in MedComm – Biomaterials and Applications

Title not available
  • 1 Dec 2026
  • MedComm – Biomaterials and Applications
Correction to “Recent Progress in 3D Printing Degradable Polylactic Acid‐Based Bone Repair Scaffold for the Application of Cancellous Bone Defect”
  • 20 Oct 2026
  • MedComm – Biomaterials and Applications
Correction to “Applications of Scanning Ion Conductance Microscope in Biomedical Fields”
  • 20 Oct 2026
  • MedComm – Biomaterials and Applications
Correction to “Biomedical Applications and Prospects of Temperature‐Orchestrated Photothermal Therapy”
  • 20 Oct 2026
  • MedComm – Biomaterials and Applications
Correction to “Nanotechnology‐Based CRISPR/Cas9 Delivery System for Genome Editing in Cancer Treatment”
  • 15 Oct 2026
  • MedComm – Biomaterials and Applications
Correction to “Improving Proteolysis‐Targeting Chimera Delivery by Targeting Key Biomarkers in Tumor Endocytosis Pathways”
  • 15 Oct 2026
  • MedComm – Biomaterials and Applications
Title not available
  • 1 Dec 2026
  • MedComm – Biomaterials and Applications
Correction to “Recent Progress in 3D Printing Degradable Polylactic Acid‐Based Bone Repair Scaffold for the Application of Cancellous Bone Defect”
  • 20 Oct 2026
  • MedComm – Biomaterials and Applications
Correction to “Applications of Scanning Ion Conductance Microscope in Biomedical Fields”
  • 20 Oct 2026
  • MedComm – Biomaterials and Applications
Correction to “Biomedical Applications and Prospects of Temperature‐Orchestrated Photothermal Therapy”
  • 20 Oct 2026
  • MedComm – Biomaterials and Applications
Correction to “Nanotechnology‐Based CRISPR/Cas9 Delivery System for Genome Editing in Cancer Treatment”
  • 15 Oct 2026
  • MedComm – Biomaterials and Applications
Correction to “Improving Proteolysis‐Targeting Chimera Delivery by Targeting Key Biomarkers in Tumor Endocytosis Pathways”
  • 15 Oct 2026
  • MedComm – Biomaterials and Applications

FAQs on MedComm – Biomaterials and Applications